R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17
- PMID: 39601215
- PMCID: PMC11650383
- DOI: 10.57264/cer-2024-0212
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17
Abstract
In this update, we discuss a position statement from the National Institute of Health and Care Excellence (NICE) on the use of artificial intelligence for evidence generation and publications reviewing the use of real-world data as external control arms. Finally, we discuss a number of recent studies investigating the real-world effectiveness of glucagon-like peptide-1 receptor agonists and whether these studies are informative for reimbursement decision making.
Keywords: GLP-1RA; NICE; artificial intelligence; evidence generation; external control arms; health technology assessment; natural language processing; obesity; real-world data; real-world evidence.
Conflict of interest statement
Competing interests disclosure
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Similar articles
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18.J Comp Eff Res. 2025 Apr;14(4):e250014. doi: 10.57264/cer-2025-0014. Epub 2025 Feb 18. J Comp Eff Res. 2025. PMID: 39963965 Free PMC article.
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20.J Comp Eff Res. 2025 Sep;14(9):e250113. doi: 10.57264/cer-2025-0113. Epub 2025 Jul 23. J Comp Eff Res. 2025. PMID: 40698536 Free PMC article.
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.J Comp Eff Res. 2024 May;13(5):e240033. doi: 10.57264/cer-2024-0033. Epub 2024 Mar 28. J Comp Eff Res. 2024. PMID: 38546012 Free PMC article.
-
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16.J Comp Eff Res. 2024 Aug;13(8):e240095. doi: 10.57264/cer-2024-0095. Epub 2024 Jul 5. J Comp Eff Res. 2024. PMID: 38967245 Free PMC article.
-
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27. Value Health. 2017. PMID: 28407993 Review.
Cited by
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18.J Comp Eff Res. 2025 Apr;14(4):e250014. doi: 10.57264/cer-2025-0014. Epub 2025 Feb 18. J Comp Eff Res. 2025. PMID: 39963965 Free PMC article.
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19.J Comp Eff Res. 2025 Jul;14(7):e250063. doi: 10.57264/cer-2025-0063. Epub 2025 May 12. J Comp Eff Res. 2025. PMID: 40350777 Free PMC article.
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20.J Comp Eff Res. 2025 Sep;14(9):e250113. doi: 10.57264/cer-2025-0113. Epub 2025 Jul 23. J Comp Eff Res. 2025. PMID: 40698536 Free PMC article.
References
-
- NICE. Use of AI in evidence generation: NICE position statement. Available at: https://www.nice.org.uk/about/what-we-do/our-research-work/use-of-ai-in-...
-
- Padula WV, Kreif N, Vanness DJ et al. Machine learning methods in health economics and outcomes research – The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force. Value Health. 25(7), 1063–1080 (2022). - PubMed
-
- Hermans SJF, van der Maas NG, van Norden Y et al. Externally controlled studies using real-world data in patients with hematological cancers: a systematic review. JAMA Oncol. 10, 1426–1436 (2024). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources